[The use of actapulgite for the treatment of acute diarrhea in infants and children. Review of pediatric studies].
Epidemiological data on diarrhea due to Rotavirus are similar enough across different regions of the world to allow the pooling of clinical studies of Actapulgite for the treatment of acute diarrhea in infants and children in France and Africa. A total of 7,616 infants and children were entered into these open or placebo-controlled trials. Most patients were under two years of age, results of the analysis confirmed the antidiarrheal efficacy and safety of Actapulgite.
Zeller
J
J
Service de Pédiatrie, Hôpital Saint-Vincent de Paul, PARIS.
Bougnères
P F
PF
D000208:Acute Disease; D000293:Adolescent; D000349:Africa / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D003968:Diarrhea, Infantile / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D005602:France / Q000453:epidemiology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008274:Magnesium / Q000008:administration & dosage / Q000627:therapeutic use*; D017616:Magnesium Compounds; D012400:Rotavirus Infections / Q000150:complications*; D012825:Silicon / Q000008:administration & dosage / Q000627:therapeutic use*; D017655:Silicon Compounds
D017616:Magnesium Compounds; D017655:Silicon Compounds; D008274:Magnesium; C026325:attapulgite; D012825:Silicon
Expérience de l'Actapulgite dans le traitement des diarrhées aiguës du nourrisson et de l'enfant. Revue d'études pédiatriques.